HCA Healthcare, Inc. 2008 10-K Summary
Business Context and Reporting Period
This summary covers the fiscal year ended December 31, 2008. HCA Healthcare, Inc. is a leading U.S. health care services company operating 166 hospitals (160 general acute care, 5 psychiatric, 1 rehabilitation) and 105 freestanding surgery centers across 20 states and England. The company operates under a private ownership structure following a 2006 recapitalization, with 97.3% of common stock owned by a private investor group (Hercules Holding II, LLC) comprising affiliates of Bain Capital, KKR, Merrill Lynch, and the Frist family.
Key Financial Metrics
| Metric | 2008 | 2007 | Change |
|---|---|---|---|
| Revenues | $28,374 million | $26,858 million | +5.6% |
| Net Income | $673 million | $874 million | -23.0% |
| Operating Margin | 4.1% | 5.2% | -1.1 pts |
| Provision for Doubtful Accounts | $3,409 million (12.0% of Rev) | $3,130 million (11.7% of Rev) | +0.3 pts |
| Interest Expense | $2,021 million | $2,215 million | -8.8% |
| Total Debt | $26,989 million | $27,308 million | -1.2% |
| Cash from Operations | $1,797 million | $1,396 million | +28.7% |
| Working Capital | $2,391 million | $2,356 million | +1.5% |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated revenues increased 5.6%, driven by a 5.2% increase in revenue per equivalent admission and a 0.5% increase in equivalent admissions. Same-facility revenue grew 7.0%.
- Profitability Decline: Net income decreased 23.0% to $673 million. This decline was primarily due to a significant reduction in non-recurring gains on sales of facilities ($97 million in 2008 vs. $471 million in 2007) and an increase in the provision for doubtful accounts.
- Bad Debt Pressure: The provision for doubtful accounts rose to 12.0% of revenues (from 11.7% in 2007), reflecting increased uninsured admissions and economic downturn pressures. The allowance for doubtful accounts represented 93% of the $5.838 billion patient due accounts receivable balance.
- Volume Trends: Consolidated admissions declined 0.7%, while inpatient surgical volumes declined 4.5%. Conversely, emergency room visits increased 2.5%.
- Interest Costs: Interest expense decreased by $194 million due to reductions in the average debt balance and average interest rate (6.9% in 2008 vs. 7.6% in 2007).
Guidance, Outlook, and Risks
Management Commentary: Management expects continued pressure on operating margins due to rising labor costs, increased uninsured populations, and payer mix deterioration. The company anticipates that same-facility uninsured emergency room visits and admissions may continue to increase if economic trends persist.
Key Risks and Contingencies:
- High Leverage: Total indebtedness of $26.989 billion creates significant refinancing risk, with $14.052 billion of senior secured credit facilities maturing in 2012 and 2013. The company faces restrictions on dividends and additional indebtedness.
- Regulatory Environment: Significant exposure to changes in Medicare and Medicaid reimbursement rates. The company is subject to the Corporate Integrity Agreement (CIA) which expired in January 2009, though reporting obligations continue. Risks include potential penalties from the False Claims Act and Stark Law violations.
- Investment Liquidity: The company's insurance subsidiary holds $536 million in auction rate securities (ARS) that have experienced failed auctions, creating potential liquidity constraints and impairment risks.
- Geographic Concentration: 51% of consolidated revenues are generated from facilities in Florida and Texas, exposing the company to regional regulatory and economic shifts.
Investor Verification Checklist
- Debt Refinancing: Verify the company's ability to refinance the $14 billion in senior secured credit facilities maturing in 2012-2013 given current credit market conditions.
- Bad Debt Trajectory: Monitor the trend of the provision for doubtful accounts as a percentage of revenue, specifically regarding the collectibility of the $5.8 billion patient due receivables.
- Regulatory Settlements: Review the final report submitted under the expired Corporate Integrity Agreement and any subsequent findings from the Office of Inspector General.
- Auction Rate Securities: Assess the potential for other-than-temporary impairment charges on the $536 million ARS portfolio held by the insurance subsidiary.
- Operational Volume: Track same-facility admission trends and surgical volumes to gauge the impact of payer mix shifts and competition from ambulatory surgery centers.